All Updates

All Updates

icon
Filter
Partnerships
Illumina partners with National Cancer Center Singapore to study the genomics of lymphoma
Precision Medicine
Jul 3, 2024
This week:
Partnerships
MGI Tech and Predica Diagnostics collaborate to develop Predica's targeted RNA sequencing tests
Precision Medicine
Jul 11, 2024
Partnerships
Renalytix partners with Steno Diabetes Center to advance precision medicine solutions for diabetes and chronic kidney disease
Precision Medicine
Jul 11, 2024
Partnerships
Myriad Genetics and Personalis cross-license patents for tumor-informed cancer treatment tests
Precision Medicine
Jul 11, 2024
Funding
Element Biosciences raises USD 277 million in Series D funding to commercialize AVITI DNA sequencer and support AVITI24 launch
Precision Medicine
Jul 11, 2024
Funding
Jacobi Robotics raises USD 5 million in seed funding to expand capacity
Smart Factory
Jul 11, 2024
M&A
Formlabs acquires Micronics for undisclosed sum to develop next-generation SLS printers
Additive Manufacturing
Jul 11, 2024
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Jul 11, 2024
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Jul 11, 2024
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Jul 11, 2024
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Jul 11, 2024
Precision Medicine

Precision Medicine

Jul 3, 2024

Illumina partners with National Cancer Center Singapore to study the genomics of lymphoma

Partnerships

  • Illumina has announced a research collaboration with the National Cancer Center Singapore (NCCS) to study the genomics of lymphoma among Asians.

  • Under the research agreement, the partners will use Illumina’s genome sequencing technology platforms, such as the NovaSeq 6000 to profile the genomes of young adult lymphoma patients from an Asian multiethnic cohort. The research is aimed toward helping in the diagnosis and treatment of the disease, including over 1,000 patients in Singapore.

  • Analyst QuickTake:  In early 2022, San Diego-based Illumina began working with the National Cancer Center Japan on a study of genomics of nasopharyngeal carcinoma in Asian patients. In this study, Illumina used its TruSight Oncology 500 ctDNA to do a genomic analysis of blood samples of up to 96 patients with nasopharynx cancer. The project was initiated as a part of a collaborative study under the Asian Clinical Trials Network for Cancers (ATLAS) project.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.